Forskning
Udskriv Udskriv
Switch language
Region Hovedstaden - en del af Københavns Universitetshospital
Udgivet

Identification of new sensitive biomarkers for the in vivo response to interferon-beta treatment in multiple sclerosis using DNA-array evaluation

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  1. Deep phenotyping of facioscapulohumeral muscular dystrophy type 2 by magnetic resonance imaging

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. More precise phenotyping of cluster headache using prospective attack reports

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Randomized trial of facilitated subcutaneous immunoglobulin in multifocal motor neuropathy

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  4. Acute endovascular reperfusion treatment in patients with ischaemic stroke and large-vessel occlusion (Denmark 2011–2017)

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  5. Disturbed sleep in cluster headache is not the result of transient processes associated with the cluster period

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  1. MAIT cell subtypes in multiple sclerosis

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Amyloid transthyretinkardiomyopati

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Early Intrathecal T Helper 17.1 Cell Activity in Huntington Disease

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  4. Cytomegalovirus-specific CD8+ T-cell responses are associated with arterial blood pressure in people living with HIV

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

Vis graf over relationer
Neutralizing antibodies (NAbs) occur in a proportion of multiple sclerosis (MS) patients treated with interferon (IFN)-beta. NAbs impair the effect of treatment. The biological effect of IFN-beta can be measured as the induction of the myxovirus resistance protein A (MxA) molecule. However, other markers could be more sensitive for evaluating the response to IFN-beta. We used DNA array analysis to identify genes that are strongly induced in blood cells by IFN-beta, and measured their expression in MS patients with different NAb levels.
OriginalsprogEngelsk
TidsskriftEuropean Journal of Neurology
Vol/bind16
Udgave nummer12
Sider (fra-til)1291-8
Antal sider8
ISSN1351-5101
DOI
StatusUdgivet - 2009

ID: 33228103